343 related articles for article (PubMed ID: 21056604)
1. Human cytomegalovirus immunity and immune evasion.
Jackson SE; Mason GM; Wills MR
Virus Res; 2011 May; 157(2):151-60. PubMed ID: 21056604
[TBL] [Abstract][Full Text] [Related]
2. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
3. Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection.
Jackson SE; Sedikides GX; Okecha G; Wills MR
Med Microbiol Immunol; 2019 Aug; 208(3-4):375-389. PubMed ID: 30895366
[TBL] [Abstract][Full Text] [Related]
4. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
Manandhar T; Hò GT; Pump WC; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344940
[TBL] [Abstract][Full Text] [Related]
5. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
Front Immunol; 2018; 9():1129. PubMed ID: 29887865
[TBL] [Abstract][Full Text] [Related]
6. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells.
Vieira Braga FA; Hertoghs KM; van Lier RA; van Gisbergen KP
Eur J Immunol; 2015 Sep; 45(9):2433-45. PubMed ID: 26228786
[TBL] [Abstract][Full Text] [Related]
9. CMV immune evasion and manipulation of the immune system with aging.
Jackson SE; Redeker A; Arens R; van Baarle D; van den Berg SPH; Benedict CA; Čičin-Šain L; Hill AB; Wills MR
Geroscience; 2017 Jun; 39(3):273-291. PubMed ID: 28647908
[TBL] [Abstract][Full Text] [Related]
10. The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.
Cheung AK; Gottlieb DJ; Plachter B; Pepperl-Klindworth S; Avdic S; Cunningham AL; Abendroth A; Slobedman B
Blood; 2009 Nov; 114(19):4128-37. PubMed ID: 19706889
[TBL] [Abstract][Full Text] [Related]
11. Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses.
Wang ECY; Pjechova M; Nightingale K; Vlahava VM; Patel M; Ruckova E; Forbes SK; Nobre L; Antrobus R; Roberts D; Fielding CA; Seirafian S; Davies J; Murrell I; Lau B; Wilkie GS; Suárez NM; Stanton RJ; Vojtesek B; Davison A; Lehner PJ; Weekes MP; Wilkinson GWG; Tomasec P
Proc Natl Acad Sci U S A; 2018 May; 115(19):4998-5003. PubMed ID: 29691324
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
[TBL] [Abstract][Full Text] [Related]
13. Diverse immune evasion strategies by human cytomegalovirus.
Noriega V; Redmann V; Gardner T; Tortorella D
Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
[TBL] [Abstract][Full Text] [Related]
14. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
[TBL] [Abstract][Full Text] [Related]
15. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
[TBL] [Abstract][Full Text] [Related]
16. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.
Crawford LB; Tempel R; Streblow DN; Kreklywich C; Smith P; Picker LJ; Nelson JA; Caposio P
Sci Rep; 2017 Apr; 7(1):937. PubMed ID: 28428537
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.
Wu Z; Frascaroli G; Bayer C; Schmal T; Mertens T
J Virol; 2015 Jun; 89(12):6435-41. PubMed ID: 25855747
[TBL] [Abstract][Full Text] [Related]
20. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
Front Immunol; 2018; 9():2734. PubMed ID: 30524448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
